Piper Sandler raised the firm’s price target on Braze (BRZE) to $50 from $38 and keeps an Overweight rating on the shares. The firm came away from Q2 encouraged, given the $8.6M top-line beat, cRPO growth acceleration to 27% year-over-year, in-period NRR improvement, and meaningful raises to full-year top-line and bottom-line guidance suggest Braze is executing well and making the right decisions to differentiate as a modern customer engagement solution in the AI era.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRZE:
- Braze price target raised to $52 from $50 at Citi
- Braze’s Strong Performance and Growth Potential: A Buy Rating Reinforced by Robust Revenue, Strategic Positioning, and Upside Potential
- Braze price target raised to $39 from $35 at Barclays
- Braze, Inc. Reports Strong Q2 2026 Financial Results
- Closing Bell Movers: Broadcom up 4%, Lululemon slips 15% after earnings